Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Flexeril	O
Attending:	O
___.	O
Chief	O
Complaint:	O
abnormal	O
thyroid	O
labs,	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
hx	O
recurrent	O
L	O
pleural	O
effusions,	O
CAD	O
s/p	O
CABG	O
___	O
(LIMA-LAD,	O
SVG-D1,	O
SVG	O
to	O
OM,	O
SVG	O
to	O
RCA),	O
severe	O
AS	O
s/p	O
bioAVR	O
___,	O
A	O
fib	O
on	O
Eliquis	O
and	O
amiodarone,	O
CLL,	O
who	O
presents	O
for	O
abnormal	O
labs	O
and	O
weakness.	O
Patient	O
had	O
TSH	O
of	O
98	O
@	O
cardiologist	O
office	O
2	O
days	O
ago	O
w/	O
free	O
T3	O
0.51,	O
free	O
T4	O
0.30.	O
They	O
instructed	O
the	O
pt	O
to	O
hold	O
his	O
amiodarone	O
___	O
concern	O
for	O
toxicity.	O
No	O
hx	O
thyroid	O
disease.	O
Pt	O
reports	O
he	O
has	O
been	O
completely	O
asymptomatic	O
recently.	O
He	O
and	O
his	O
wife	O
are	O
currently	O
staying	O
at	O
a	O
hotel	O
after	O
being	O
evacuated	O
___	O
the	O
fires	O
last	O
night	O
in	O
___.	O
They	O
report	O
that	O
he	O
has	O
"fluid	O
issues"	O
after	O
his	O
heart	O
surgeries	O
and	O
his	O
daily	O
Lasix	O
dosing	O
was	O
recently	O
increased	O
from	O
40mg	O
qd	O
to	O
80mg	O
qd	O
approximately	O
2	O
weeks	O
ago.	O
They	O
have	O
not	O
noticed	O
any	O
change	O
in	O
his	O
leg	O
edema	O
with	O
the	O
increase	O
and	O
he	O
reports	O
it	O
is	O
currently	O
worse	O
than	O
usual.	O
Due	O
to	O
the	O
evacuation	O
and	O
forgetting	O
to	O
bring	O
his	O
medication,	O
he	O
has	O
not	O
taken	O
any	O
of	O
his	O
medications	O
since	O
yesterday.	O
Denies	O
chest	O
pain.	O
Reports	O
ongoing	O
dyspnea	O
with	O
talking,	O
denies	O
dyspnea	O
at	O
other	O
times	O
or	O
with	O
exertion.	O
Denies	O
orthopnea,	O
PND.	O
Pt's	O
cardiology	O
office	O
can	O
be	O
reached	O
at	O
___.	O
In	O
the	O
ED:	O
Initial	O
vital	O
signs	O
were	O
notable	O
for:	O
___	O
61	O
18	O
107/55	O
99%RA	O
Exam	O
notable	O
for:	O
Gen	O
app:	O
NAD,	O
no	O
resp	O
distress	O
HEENT:	O
no	O
thyroid	O
enlargement,	O
no	O
palpable	O
thyroid	O
nodules.	O
CV:	O
There	O
is	O
a	O
loud	O
S2.	O
RRR.	O
Lungs:	O
Faint	O
rales	O
in	O
lower	O
lobes	O
bilaterally.	O
Extrem:	O
2+	O
bilateral	O
pitting	O
edema	O
in	O
lower	O
extreme	O
Labs	O
were	O
notable	O
for:	O
WBC	O
7.8	O
Hb	O
8.2	O
Plt	O
132	O
(baselin	O
Hb	O
~9,	O
Plt	O
~200)\	O
137	O
|	O
95	O
|	O
___	O
5.6	O
|	O
30	O
|	O
1.5	O
(baseline	O
1.2)	O
Ca	O
8.7	O
Mg	O
2.3	O
P	O
3.2	O
proBNP	O
___	O
Outside	O
labs	O
from	O
2	O
days	O
ago:	O
TSH	O
98,	O
free	O
T3	O
0.51,	O
free	O
T4	O
0.30	O
Studies	O
performed	O
include:	O
Chest	O
x-ray:	O
No	O
significant	O
change	O
from	O
most	O
recent	O
prior	O
exam	O
with	O
near	O
complete	O
opacification	O
of	O
the	O
left	O
hemithorax	O
due	O
likely	O
due	O
to	O
a	O
large	O
left	O
pleural	O
effusion	O
(comparison	O
___	O
Patient	O
was	O
given:	O
150	O
mg	O
ranitidine	O
Metoprolol	O
succinate	O
xl	O
25	O
mg	O
Simvastatin	O
40	O
mg	O
Apixaban	O
5	O
mg	O
IV	O
furosemide	O
80	O
mg	O
-	O
output	O
not	O
documented	O
Consults:	O
None	O
Vitals	O
on	O
transfer:	O
97.6	O
58	O
96/46	O
18	O
98%	O
RA	O
Upon	O
arrival	O
to	O
the	O
floor,	O
pt	O
confirms	O
the	O
above	O
history.	O
He	O
says	O
he	O
left	O
___	O
due	O
to	O
recent	O
explosions	O
to	O
stay	O
in	O
___	O
___	O
overnight.	O
He	O
was	O
on	O
the	O
way	O
home	O
when	O
his	O
cardiologist	O
in	O
___	O
called	O
about	O
his	O
abnormal	O
labs,	O
which	O
is	O
why	O
he	O
presented	O
to	O
the	O
hospital.	O
He	O
denies	O
feeling	O
any	O
acutely	O
worse	O
than	O
usual.	O
On	O
review	O
of	O
systems,	O
he	O
endorses	O
worsening	O
vision	O
for	O
the	O
past	O
___	O
months	O
with	O
occasional	O
episodes	O
of	O
double	O
vision.	O
He	O
endorses	O
constipation	B-Constipation
to	O
sometimes	O
3	O
days	O
between	O
bowel	O
movements	O
for	O
the	O
past	O
___	O
months.	O
Over	O
that	O
same	O
period	O
of	O
time	O
his	O
cardiologist	O
has	O
been	O
attempting	O
to	O
increase	O
his	O
dose	O
of	O
lasix	O
to	O
decrease	O
the	O
edema	O
in	O
the	O
ankles	O
-	O
increased	O
to	O
80	O
mg	O
daily	O
from	O
20	O
mg	O
2	O
months	O
ago.	O
He	O
denies	O
palpitations,	O
headaches,	O
chest	O
pain	O
or	O
pain	O
anywhere.	O
Denies	O
recent	O
illness,	O
FH	O
of	O
thyroid	O
problems.	O
Past	O
Medical	O
History:	O
-	O
CLL	O
previously	O
on	O
ibrutinib	O
-	O
Psoriasis	O
-	O
Insomnia	O
-	O
BPH	O
-	O
Prior	O
TIA	O
(right	O
leg	O
weakness	O
and	O
numbness)	O
-	O
Chronic	O
low	O
back	O
pain	O
-	O
Cataract	O
surgery	O
-	O
Severe	O
AS	O
with	O
AVR	O
in	O
___	O
-	O
AVR,	O
CABG	O
___	O
(LIMA	O
to	O
LAD,	O
reverse	O
saphenous	O
vein	O
to	O
diagonal	O
branch,	O
marginal	O
branch,	O
and	O
RCA)	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
secondary	O
to	O
MI	O
aged	O
___.	O
Mother	O
died	O
secondary	O
to	O
cancer.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
97.6	O
58	O
96/46	O
18	O
98%	O
RA	O
GENERAL:	O
Pleasant	O
alert	O
and	O
interactive	O
kyphotic	O
man	O
sitting	O
in	O
bed	O
in	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
NECK:	O
Thyroid	O
is	O
normal	O
in	O
size	O
and	O
texture,	O
elevates	O
with	O
swallowing.	O
No	O
palpable	O
nodules	O
or	O
goiter.	O
No	O
cervical	O
lymphadenopathy.	O
No	O
visible	O
JVP.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Significantly	O
decreased	O
to	O
absent	O
breath	O
sounds	O
in	O
all	O
left	O
lung	O
fields.	O
Right	O
lung	O
fields	O
with	O
occasional	O
crackles	O
in	O
lower	O
lobes,	O
no	O
wheezes.	O
No	O
increased	O
work	O
of	O
breathing,	O
accessory	O
muscle	O
use,	O
or	O
tachypnea.	O
BACK:	O
No	O
spinous	O
process	O
tenderness.	O
No	O
CVA	O
tenderness.	O
Kyphotic.	O
ABDOMEN:	O
Normal	O
bowel	O
sounds,	O
non	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
EXTREMITIES:	O
No	O
clubbing	O
or	O
cyanosis.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
Significant	O
___	O
puffy	O
edema	O
without	O
any	O
skin	O
changes	O
bilaterally	O
in	O
the	O
ankles	O
extending	O
up	O
to	O
1+	O
edema	O
in	O
the	O
mid	O
shins	O
SKIN:	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rash.	O
NEUROLOGIC:	O
CN2-12	O
intact.	O
___	O
strength	O
throughout.	O
Normal	O
sensation.	O
2+	O
biceps	O
reflexes,	O
1+	O
patellar	O
reflex.	O
AOx3.	B-Delirium
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
___	O
0736	O
Temp:	O
98.3	O
PO	O
BP:	O
102/46	O
HR:	O
51	O
RR:	O
18	O
O2	O
sat:	O
99%	O
O2	O
delivery:	O
1L	O
GENERAL:	O
Pleasant,	O
alert	O
and	O
interactive,	O
kyphotic	O
man	O
sitting	O
up	O
in	O
bed	O
in	O
NAD.	O
HEENT:	O
NC/AT,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
CARDIAC:	O
Bradycardic	O
but	O
regular	O
rhythm.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
+Decreased	O
breath	O
sounds	O
in	O
left	O
lung.	O
Right	O
lung	O
mildly	O
diminished	O
at	O
the	O
base.	O
No	O
increased	O
work	O
of	O
breathing,	O
accessory	O
muscle	O
use,	O
or	O
tachypnea.	O
ABDOMEN:	O
+BS,	O
non-distended,	O
non-tender,	O
no	O
organomegaly.	O
EXTREMITIES:	O
No	O
clubbing	O
or	O
cyanosis.	O
___	O
BLE	O
R>L	O
edema	O
up	O
to	O
mid-shins	O
SKIN:	O
Warm	O
and	O
well	O
perfused.	O
NEUROLOGIC:	O
AOx3.	B-Delirium
+Delayed	O
relaxation	O
of	O
reflexes.	O
No	O
focal	O
neurologic	O
deficits.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
02:37PM	O
PLT	O
COUNT-132*	O
___	O
02:37PM	O
NEUTS-61.8	O
___	O
MONOS-6.5	O
EOS-0.4*	O
BASOS-0.4	O
IM	O
___	O
AbsNeut-4.82	O
AbsLymp-2.36	O
AbsMono-0.51	O
AbsEos-0.03*	O
AbsBaso-0.03	O
___	O
02:37PM	O
WBC-7.8	O
RBC-2.72*	O
HGB-8.2*	O
HCT-27.0*	O
MCV-99*	O
MCH-30.1	O
MCHC-30.4*	O
RDW-20.0*	O
RDWSD-71.9*	O
___	O
02:37PM	O
CALCIUM-8.7	O
PHOSPHATE-3.2	O
MAGNESIUM-2.3	O
___	O
02:37PM	O
___	O
02:37PM	O
GLUCOSE-94	O
UREA	O
N-21*	O
CREAT-1.5*	O
SODIUM-137	O
POTASSIUM-5.6*	O
CHLORIDE-95*	O
TOTAL	O
CO2-30	O
ANION	O
GAP-12	O
PERTINENT	O
LABS:	O
===============	O
___	O
08:10AM	O
BLOOD	O
calTIBC-200*	O
Ferritn-1061*	O
TRF-154*	O
___	O
08:10AM	O
BLOOD	O
TSH-85*	O
___	O
08:10AM	O
BLOOD	O
T3-33*	O
Free	O
T4-0.3*	O
___	O
08:10AM	O
BLOOD	O
Cortsol-17.7	O
___	O
08:10AM	O
BLOOD	O
antiTPO-PND	O
___	O
01:27AM	O
BLOOD	O
Lactate-1.1	O
___	O
01:51PM	O
BLOOD	O
Lactate-1.4	O
___	O
01:51AM	O
BLOOD	O
Lactate-0.8	O
MICROBIOLOGY:	O
=============	O
___	O
8:22	O
am	O
BLOOD	O
CULTURE	O
#2.	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
__________________________________________________________	O
___	O
5:02	O
pm	O
URINE	O
Source:	O
___.	O
URINE	O
CULTURE	O
(Pending):	O
__________________________________________________________	O
___	O
1:35	O
pm	O
BLOOD	O
CULTURE	O
#1.	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
__________________________________________________________	O
___	O
2:35	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
No	O
growth	O
to	O
date.	O
__________________________________________________________	O
___	O
1:15	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
No	O
growth	O
to	O
date.	O
IMAGING:	O
========	O
___	O
CXR	O
FINDINGS:	O
PA	O
and	O
lateral	O
views	O
of	O
the	O
chest	O
provided.	O
Midline	O
sternotomy	O
wires	O
and	O
aortic	O
valve	O
replacement	O
as	O
well	O
as	O
mediastinal	O
clips	O
noted.	O
Near	O
complete	O
opacification	O
of	O
the	O
left	O
hemithorax	O
is	O
again	O
noted	O
with	O
mild	O
residual	O
aeration	O
in	O
the	O
left	O
upper	O
lobe.	O
Findings	O
are	O
secondary	O
to	O
known	O
large	O
pleural	O
effusion.	O
The	O
right	O
lung	O
is	O
essentially	O
clear	O
with	O
minimal	O
right	O
basal	O
atelectasis	O
noted.	O
The	O
heart	O
size	O
cannot	O
be	O
assessed.	O
No	O
gross	O
signs	O
for	O
edema.	O
Mediastinal	O
contour	O
appears	O
grossly	O
unchanged.	O
Imaged	O
bony	O
structures	O
are	O
intact.	O
IMPRESSION:	O
No	O
significant	O
change	O
from	O
most	O
recent	O
prior	O
exam	O
with	O
near	O
complete	O
opacification	O
of	O
the	O
left	O
hemithorax	O
du	O
likely	O
due	O
to	O
a	O
large	O
left	O
pleural	O
effusion.	O
DISCHARGE	O
LABS:	O
===============	O
___	O
08:22AM	O
BLOOD	O
WBC-7.7	O
RBC-2.86*	O
Hgb-8.6*	O
Hct-28.0*	O
MCV-98	O
MCH-30.1	O
MCHC-30.7*	O
RDW-21.5*	O
RDWSD-75.9*	O
Plt	O
___	O
___	O
08:22AM	O
BLOOD	O
Plt	O
___	O
___	O
08:22AM	O
BLOOD	O
Glucose-92	O
UreaN-20	O
Creat-1.3*	O
Na-135	O
K-4.5	O
Cl-94*	O
HCO3-28	O
AnGap-13	O
___	O
08:22AM	O
BLOOD	O
ALT-11	O
AST-21	O
LD(LDH)-422*	O
AlkPhos-81	O
TotBili-1.0	O
DirBili-0.3	O
IndBili-0.7	O
___	O
08:22AM	O
BLOOD	O
Albumin-3.0*	O
Calcium-8.3*	O
Phos-3.0	O
Mg-2.2	O
UricAcd-6.___RIEF	O
HOSPITAL	O
SUMMARY:	O
=======================	O
___	O
with	O
hx	O
of	O
recurrent	O
L	O
pleural	O
effusions,	O
CAD	O
s/p	O
CABG	O
___	O
(LIMA-LAD,	O
SVG-D1,	O
SVG	O
to	O
OM,	O
SVG	O
to	O
RCA),	O
severe	O
AS	O
s/p	O
bioAVR	O
___,	O
A	O
fib	O
on	O
Eliquis	O
and	O
amiodarone,	O
CLL	O
presenting	O
with	O
TSH	O
of	O
98	O
found	O
on	O
clinic	O
visit	O
2	O
days	O
ago	O
and	O
several	O
months	O
of	O
gradually	O
worsening	O
weakness,	O
worsening	O
vision,	O
and	O
constipation	O
in	O
the	O
setting	O
of	O
profound	O
hypothyroidism.	O
TRANSITIONAL	O
ISSUES:	O
====================	O
[	O
]	O
Patient	O
started	O
on	O
levothyroxine	O
50mcg	O
qd	O
while	O
inpatient.	O
Will	O
need	O
to	O
follow	O
up	O
with	O
endocrinology	O
in	O
~4	O
weeks.	O
Can	O
either	O
see	O
an	O
endocrinologist	O
that	O
his	O
PCP	O
recommends	O
or	O
can	O
call	O
___	O
to	O
set	O
up	O
an	O
appointment	O
at	O
___	O
Endocrinology.	O
[	O
]	O
Patient	O
will	O
need	O
thyroid	O
function	O
tests	O
checked	O
on	O
___.	O
[	O
]	O
Anti-TPO	O
antibodies	O
pending	O
at	O
time	O
of	O
discharge.	O
Primary	O
inpatient	O
team	O
will	O
follow	O
up	O
on	O
these	O
results	O
(although	O
expect	O
them	O
to	O
be	O
negative	O
given	O
hypothyroidism	O
likely	O
from	O
amiodarone	O
toxicity).	O
[	O
]	O
Amiodarone	O
was	O
held	O
as	O
it	O
is	O
likely	O
etiology	O
of	O
hypothyroidism.	O
Patient	O
should	O
discuss	O
with	O
his	O
cardiologist	O
prior	O
to	O
restarting.	O
[	O
]	O
Metoprolol	O
and	O
Lasix	O
were	O
held	O
in	O
the	O
setting	O
of	O
hypotension	O
and	O
bradycardia	O
(40-50s).	O
Patient	O
should	O
discuss	O
with	O
his	O
cardiologist	O
prior	O
to	O
restarting	O
these	O
medications.	O
[	O
]	O
If	O
patient	O
continues	O
to	O
be	O
bradycardic	O
and	O
hypotensive	O
despite	O
hypothyroid	O
treatment	O
and	O
holding	O
metoprolol,	O
can	O
consider	O
further	O
workup	O
for	O
autonomic	O
instability.	O
[	O
]	O
Patient	O
with	O
___	O
on	O
admission,	O
Creatinine	O
up	O
to	O
1.5	O
on	O
admission	O
from	O
1.2	O
on	O
last	O
discharge.	O
Creatinine	O
on	O
day	O
of	O
discharge	O
was	O
1.3.	O
Please	O
recheck	O
Cr	O
1	O
week	O
from	O
discharge	O
at	O
PCP	O
follow	O
up.	O
[	O
]	O
Patient	O
with	O
chronic	O
Left	O
pleural	O
effusion	O
s/p	O
VATS.	O
He	O
is	O
asymptomatic	O
and	O
should	O
follow	O
up	O
with	O
IP	O
as	O
outpatient	O
as	O
needed.	O
ACUTE	O
ISSUES:	O
=============	O
#	O
Hypothyroidism	O
Pt	O
with	O
elevated	O
TSH,	O
low	O
FT4	O
and	O
FT3	O
found	O
on	O
labs	O
at	O
OSH	O
Cardiology.	O
Symptoms	O
included	O
general	O
weakness,	O
vision	O
changes,	O
and	O
constipation	B-Constipation
for	O
several	O
weeks	O
prior	O
to	O
admission.	O
Presentation	O
not	O
consistent	O
with	O
myxedema	O
coma	O
at	O
time	O
of	O
admission.	O
Etiology	O
of	O
hypothyroidism	O
thought	O
most	O
likely	O
secondary	O
to	O
Amiodarone	O
toxicity,	O
however	O
of	O
note	O
was	O
found	O
to	O
have	O
euthyroid	O
sick	O
syndrome	O
in	O
the	O
___	O
given	O
mildly	O
elevated	O
TSH	O
16,	O
FT3	O
1.62,	O
and	O
FT4	O
1.0.	O
Anti-TPO	O
antibodies	O
were	O
pending	O
at	O
time	O
of	O
discharge.	O
Endocrine	O
was	O
consulted	O
and	O
recommended	O
starting	O
levothyroxine.	O
Patient	O
was	O
discharged	O
on	O
levothyroxine	O
50mcg	O
qd	O
with	O
plan	O
to	O
uptitrate	O
in	O
~4	O
weeks	O
as	O
an	O
outpatient.	O
He	O
will	O
follow	O
up	O
either	O
at	O
___	O
endocrinology	O
or	O
with	O
an	O
endocrinologist	O
of	O
his	O
PCP's	O
recommendation.	O
Thyroid	O
function	O
tests	O
will	O
be	O
rechecked	O
on	O
___.	O
Amiodarone	O
was	O
held	O
on	O
admission	O
and	O
will	O
not	O
be	O
restarted	O
until	O
patient	O
discusses	O
with	O
his	O
cardiologist.	O
He	O
was	O
started	O
on	O
a	O
bowel	O
regimen	O
for	O
constipation.	O
#	O
Recurrent	O
triggers	O
#	O
Hypotension	O
#	O
Bradycardia	O
Patient	O
with	O
multiple	O
episodes	O
of	O
hypotension	O
with	O
SBP	O
in	O
60-70s	O
during	O
admission.	O
Patient	O
reported	O
having	O
poor	O
PO	O
fluid	O
intake	O
for	O
the	O
past	O
several	O
weeks.	O
Given	O
poor	O
PO	O
intake,	O
IV	O
Lasix	O
in	O
the	O
ED,	O
and	O
home	O
metoprolol,	O
hypotension	O
was	O
thought	O
most	O
concerning	O
for	O
hypovolemia	O
with	O
concurrent	O
bradycardia	O
and	O
hypothyroidism.	O
Of	O
note,	O
his	O
SBPs	O
from	O
prior	O
hospitalizations	O
and	O
outpatient	O
records	O
was	O
90-100s.	O
During	O
episodes	O
of	O
hypotension,	O
lactate	O
was	O
normal.	O
He	O
received	O
250cc	O
LR	O
boluses	O
when	O
necessary,	O
but	O
only	O
gentle	O
fluid	O
administration	O
given	O
chronic	O
difficulties	O
with	O
hypervolemia	O
in	O
the	O
setting	O
of	O
severe	O
aortic	O
stenosis.	O
Metoprolol	O
was	O
held	O
on	O
admission.	O
Hypothyroidism	O
was	O
treated	O
as	O
above.	O
Patient	O
should	O
consider	O
autonomic	O
instability	O
workup	O
if	O
still	O
bradycardic	O
despite	O
treating	O
hypothyroidism	O
and	O
holding	O
metoprolol.	O
#	O
___	O
on	O
CKD	O
Patient	O
presented	O
with	O
creatinine	O
of	O
1.5	O
and	O
K	O
5.6	O
on	O
admission,	O
up	O
from	O
1.2	O
on	O
last	O
discharge.	O
Patient	O
received	O
80mg	O
IV	O
Lasix	O
in	O
the	O
ED	O
after	O
labs	O
were	O
drawn.	O
Patient	O
was	O
euvolemic	O
on	O
exam.	O
___	O
was	O
felt	O
to	O
be	O
due	O
to	O
hypovolemia	O
in	O
the	O
setting	O
of	O
poor	O
PO	O
intake	O
and	O
recent	O
Lasix.	O
Patient	O
had	O
one	O
isolated	O
TTE	O
on	O
___	O
with	O
EF	O
40%,	O
but	O
several	O
days	O
later	O
EF>55%;	O
unclear	O
if	O
this	O
represented	O
recovered	O
HF	O
or	O
(more	O
likely)	O
isolated	O
spurious	O
finding	O
on	O
a	O
suboptimal	O
quality	O
TTE	O
performed	O
while	O
patient	O
was	O
in	O
atrial	O
tachyarrhythmia.	O
Patient	O
received	O
gentle	O
fluid	O
administration	O
given	O
h/o	O
hypervolemia	O
___	O
severe	O
aortic	O
stenosis.	O
Creatinine	O
was	O
monitored	O
and	O
was	O
1.3	O
on	O
day	O
of	O
discharge.	O
Creatinine	O
should	O
be	O
checked	O
by	O
PCP	O
1	O
week	O
after	O
discharge.	O
Home	O
Lasix	O
was	O
held	O
on	O
admission	O
and	O
patient	O
should	O
discuss	O
with	O
his	O
cardiologist	O
prior	O
to	O
restarting.	O
#	O
Anemia	O
Anemia	O
on	O
admission	O
thought	O
likely	O
secondary	O
to	O
CLL	O
+	O
iron	O
deficiency	O
anemia.	O
Patient	O
had	O
decrease	O
to	O
6.3	O
overnight	O
after	O
admission,	O
with	O
no	O
evidence	O
of	O
active	O
bleeding.	O
He	O
received	O
1u	O
pRBC	O
___	O
AM	O
and	O
over-responded	O
back	O
to	O
baseline	O
of	O
8.	O
Iron	O
studies	O
were	O
consistent	O
with	O
anemia	O
of	O
chronic	O
disease,	O
hemolysis	O
labs	O
indeterminate	O
(K	O
within	O
normal	O
limits,	O
LDH	O
and	O
T	O
bili	O
elevated	O
but	O
at	O
baseline).	O
Uric	O
acid	O
was	O
slightly	O
elevated	O
but	O
downtrended	O
to	O
normal	O
during	O
admission.	O
CBC	O
was	O
monitored	O
and	O
he	O
required	O
no	O
additional	O
transfusions.	O
#	O
Lower	O
extremity	O
edema	O
Patient	O
received	O
80	O
mg	O
IV	O
lasix	O
in	O
the	O
ED	O
with	O
output	O
unknown.	O
Per	O
patient,	O
edema	O
is	O
worse	O
than	O
usual	O
but	O
is	O
chronic.	O
Potential	O
etiology	O
of	O
worsening	O
edema	O
included	O
hypothyroidism.	O
Home	O
Lasix	O
was	O
held	O
given	O
hypotension	O
and	O
will	O
not	O
be	O
restarted	O
until	O
patient	O
discusses	O
with	O
outpatient	O
cardiologist.	O
#	O
Atrial	O
fibrillation	O
Patient	O
on	O
amiodarone	O
and	O
metoprolol	O
at	O
home.	O
Amiodarone	O
held	O
given	O
hypothyroidism,	O
and	O
Metoprolol	O
held	O
given	O
bradycardia	O
and	O
hypotension.	O
Patient	O
was	O
monitored	O
on	O
tele	O
and	O
remained	O
in	O
sinus	O
rhythm	O
during	O
admission.	O
He	O
was	O
continued	O
on	O
apixaban	O
5	O
BID.	O
Metoprolol	O
and	O
Amiodarone	O
were	O
held	O
on	O
discharge	O
until	O
patient	O
discusses	O
with	O
his	O
cardiologist.	O
CHRONIC	O
ISSUES:	O
===============	O
#	O
L	O
pleural	O
effusion	O
chronic	O
Patient	O
had	O
recent	O
follow	O
up	O
with	O
IP	O
on	O
___,	O
per	O
note	O
patient	O
"has	O
had	O
no	O
recurrence	O
of	O
his	O
L	O
pleural	O
effusion	O
after	O
VATS,	O
suggesting	O
that	O
he	O
has	O
pleurodesed".	O
Per	O
note,	O
at	O
the	O
time	O
he	O
was	O
not	O
symptomatic	O
and	O
continues	O
to	O
be	O
asymptomatic.	O
He	O
was	O
not	O
scheduled	O
for	O
follow	O
up	O
and	O
told	O
to	O
return	O
if	O
symptomatic.	O
Chest	O
x-ray	O
on	O
admission	O
was	O
unchanged	O
from	O
prior	O
and	O
patient	O
continues	O
to	O
be	O
asymptomatic.	O
Patient	O
should	O
continue	O
to	O
follow	O
up	O
with	O
outpatient	O
IP	O
as	O
needed.	O
#	O
Cardiac	O
constriction	O
LV/RV	O
interdependence	O
seen	O
on	O
TTE	O
___.	O
No	O
signs	O
of	O
constriction	O
on	O
physical	O
exam	O
on	O
admission.	O
Patient	O
should	O
continue	O
to	O
be	O
monitored	O
as	O
an	O
outpatient.	O
#	O
Thrombocytopenia	O
Plt	O
132	O
on	O
admission,	O
just	O
below	O
baseline	O
~200s.	O
Stable	O
at	O
131	O
on	O
day	O
of	O
discharge.	O
Etiology	O
most	O
likely	O
secondary	O
to	O
history	O
of	O
CLL.	O
Patient	O
should	O
continue	O
to	O
be	O
monitored	O
as	O
an	O
outpatient.	O
#	O
RLS	O
Patient	O
was	O
continued	O
on	O
ropinirole.	O
#	O
CAD	O
s/p	O
CABG	O
___	O
Patient	O
was	O
continued	O
on	O
home	O
ASA	O
and	O
simvastatin.	O
Home	O
metoprolol	O
was	O
held	O
as	O
above.	O
#CODE:	O
full,	O
confirmed	O
with	O
patient	O
___	O
@	O
20:15	O
#CONTACT:	O
Name	O
of	O
health	O
care	O
proxy:	O
___	O
(wife)	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
2.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
5.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
6.	O
Gabapentin	O
300	O
mg	O
PO	O
QHS	O
7.	O
Ramelteon	O
8	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
8.	O
Simvastatin	O
40	O
mg	O
PO	O
QPM	O
9.	O
Amiodarone	O
100	O
mg	O
PO	O
DAILY	O
10.	O
Furosemide	O
80	O
mg	O
PO	O
DAILY	O
11.	O
rOPINIRole	O
1	O
mg	O
PO	O
QPM	O
Discharge	O
Medications:	O
1.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
2.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
DAILY	O
RX	O
*levothyroxine	O
50	O
mcg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
Constipation	O
-	O
First	O
Line	O
Reason	O
for	O
PRN	O
duplicate	O
override:	O
Alternating	O
agents	O
for	O
similar	O
severity	O
4.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
6.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
7.	O
Gabapentin	O
300	O
mg	O
PO	O
QHS	O
8.	O
Ramelteon	O
8	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
9.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
10.	O
rOPINIRole	O
1	O
mg	O
PO	O
QPM	O
11.	O
Simvastatin	O
40	O
mg	O
PO	O
QPM	O
12.	O
HELD-	O
Amiodarone	O
100	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Amiodarone	O
until	O
you	O
discuss	O
with	O
your	O
cardiologist.	O
13.	O
HELD-	O
Furosemide	O
80	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Furosemide	O
until	O
you	O
discuss	O
with	O
your	O
cardiologist	O
14.	O
HELD-	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Metoprolol	O
Succinate	O
XL	O
until	O
you	O
discuss	O
with	O
your	O
cardiologist	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
___	O
Diagnosis:	O
Primary	O
diagnosis:	O
Hypothyroidism	O
Secondary	O
diagnoses:	O
Hypotension	O
Bradycardia	O
Acute	O
on	O
chronic	O
kidney	O
injury	O
Anemia	O
Lower	O
extremity	O
edema	O
Atrial	O
fibrillation	O
Chronic	O
left	O
pleural	O
effusion	O
Cardiac	O
constriction	O
Restless	O
leg	O
syndrome	O
Thrombocytopenia	O
Coronary	O
artery	O
disease	O
s/p	O
CABG	O
___	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you	O
at	O
the	O
___	O
___.	O
Why	O
did	O
you	O
come	O
to	O
the	O
hospital?	O
-	O
You	O
came	O
to	O
the	O
hospital	O
because	O
your	O
outpatient	O
cardiologist	O
was	O
concerned	O
about	O
your	O
thyroid	O
function.	O
What	O
did	O
you	O
receive	O
in	O
the	O
hospital?	O
-	O
You	O
were	O
started	O
on	O
a	O
medicine	O
called	O
levothyroxine	O
to	O
help	O
your	O
low	O
thyroid	O
levels.	O
We	O
think	O
that	O
your	O
decreased	O
thyroid	O
function	O
is	O
from	O
taking	O
amiodarone.	O
-	O
Your	O
heart	O
rate	O
was	O
slow	O
and	O
your	O
blood	O
pressure	O
was	O
low.	O
Your	O
home	O
metoprolol	O
and	O
Lasix	O
were	O
held	O
because	O
they	O
can	O
make	O
your	O
heart	O
beat	O
slower	O
and	O
blood	O
pressure	O
lower.	O
-	O
Your	O
red	O
blood	O
cell	O
count	O
was	O
low.	O
You	O
received	O
a	O
unit	O
of	O
red	O
blood	O
cells.	O
You	O
did	O
not	O
have	O
any	O
evidence	O
of	O
bleeding.	O
What	O
should	O
you	O
do	O
once	O
you	O
leave	O
the	O
hospital?	O
-	O
You	O
should	O
take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
(see	O
below).	O
Your	O
metoprolol,	O
amiodarone	O
and	O
Lasix	O
were	O
held	O
during	O
your	O
admission	O
and	O
should	O
not	O
be	O
restarted	O
until	O
you	O
discuss	O
with	O
your	O
cardiologist.	O
-	O
You	O
should	O
call	O
your	O
cardiologist	O
on	O
___	O
AM	O
to	O
set	O
up	O
an	O
appointment	O
this	O
week	O
to	O
discuss	O
your	O
medications.	O
-	O
You	O
should	O
also	O
call	O
your	O
primary	O
care	O
doctor	O
___	O
AM	O
to	O
set	O
up	O
an	O
appointment	O
this	O
week	O
and	O
to	O
ask	O
if	O
he/she	O
has	O
any	O
specific	O
endocrinologist	O
you	O
should	O
see.	O
-	O
If	O
your	O
primary	O
care	O
doctor	O
does	O
not	O
recommend	O
a	O
specific	O
endocrinologist,	O
you	O
can	O
call	O
___	O
to	O
set	O
up	O
an	O
appointment	O
at	O
___	O
Endocrinology.	O
We	O
wish	O
you	O
the	O
best!	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

